V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001923 | 330001092 | 1.75 | 56.6 | null | 2017-01-17 | 2017-02-17 | Cisplatin | 02 | Y | 330007502 | CISPLATIN |
| 330001924 | 330001092 | null | 15.4 | Neo-adjuvant (N) | 2015-09-08 | 2015-09-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007502 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001925 | 330001093 | 1.71 | 61.8 | Curative (C) | null | 2017-08-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007506 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001926 | 330001094 | null | 110 | Curative (C) | 2014-10-04 | 2014-10-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001927 | 330001094 | 1.51 | 83 | null | 2014-01-08 | 2014-01-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330007510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001928 | 330001094 | 1.72 | 115 | Neo-adjuvant (N) | 2015-02-17 | 2015-02-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001930 | 330001096 | 1.8 | 12.8 | Neo-adjuvant (N) | 2015-11-20 | 2015-12-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 330007522 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001931 | 330001096 | 1.55 | 54.4 | Curative (C) | 2018-01-23 | 2018-01-23 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330007522 | NOT MATCHED |
| 330001932 | 330001096 | 1.68 | 65.9 | Curative (C) | null | 2014-06-21 | Cisplatin | N | N | 330007522 | CISPLATIN |
| 330001933 | 330001097 | 1.51 | 62 | Neo-adjuvant (N) | null | 2015-07-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007528 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001934 | 330001098 | 1.64 | 77.2 | Curative (C) | 2015-04-15 | 2015-04-21 | Cisplatin 7 day | N | Y | 330007531 | CISPLATIN |
| 330001935 | 330006594 | 1.57 | 78.65 | null | null | 2014-05-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001936 | 330001099 | 1.59 | 25.8 | Neo-adjuvant (N) | 2013-09-05 | 2013-09-16 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007533 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001937 | 330001100 | 1.73 | 81 | Curative (C) | 2018-03-05 | 2018-03-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007534 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001938 | 330001101 | 1.55 | 86 | Curative (C) | 2014-08-19 | 2014-09-02 | Cisplatin 7 day | 02 | Y | 330007535 | CISPLATIN |
| 330001940 | 330001103 | 1.6 | 142 | Neo-adjuvant (N) | 2015-06-24 | 2015-07-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007540 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001941 | 330001104 | 1.69 | 79.4 | null | 2014-07-09 | 2014-07-09 | Trial Unspecified | Y | N | 330007542 | TRIAL |
| 330001942 | 330001105 | 1.79 | null | Curative (C) | 2015-04-25 | 2015-04-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007547 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001943 | 330001105 | 0.79 | 56.4 | Curative (C) | 2016-12-02 | 2016-12-10 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007547 | NOT MATCHED |
| 330001944 | 330001106 | 1.74 | 80.8 | Curative (C) | 2016-05-29 | 2016-06-24 | Cisplatin 7 day | N | Y | 330007551 | CISPLATIN |
| 330001945 | 330001107 | 1.62 | 83 | Curative (C) | null | 2013-04-23 | Cisplatin | N | N | 330007552 | CISPLATIN |
| 330001946 | 330001108 | 1.56 | 0 | Neo-adjuvant (N) | 2015-09-23 | 2015-09-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007553 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001947 | 330001109 | 0 | 95 | null | 2015-08-10 | 2015-08-10 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007554 | NOT MATCHED |
| 330001948 | 330001110 | 1.61 | 45.9 | null | 2015-09-20 | 2015-10-31 | Cisplatin | N | Y | 330007555 | CISPLATIN |
| 330001949 | 330006596 | 1.66 | null | Curative (C) | null | 2016-10-29 | NB HRNBL | null | N | 330007556 | NOT MATCHED |
| 330001950 | 330006596 | 0 | 81.2 | Curative (C) | 2015-07-16 | 2015-07-16 | NB HRNBL-1 TVD | N | N | 330007556 | NOT MATCHED |
| 330001951 | 330006596 | 1.58 | 0 | Neo-adjuvant (N) | 2014-08-11 | 2014-08-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007556 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001952 | 330001111 | null | 64.3 | Neo-adjuvant (N) | 2014-05-08 | 2014-05-18 | Trial Unspecified | Y | N | 330007562 | TRIAL |
| 330001953 | 330006597 | 1.63 | null | null | 2016-07-28 | 2016-08-20 | Cisplatin 7 day | 02 | N | 330007563 | CISPLATIN |
| 330001954 | 330001112 | null | 79.8 | Curative (C) | 2015-10-06 | 2015-10-06 | Cisplatin | N | Y | 330007564 | CISPLATIN |
| 330001955 | 330001113 | 1.9 | 62.1 | Curative (C) | 2017-07-12 | 2017-08-02 | Cisplatin | N | null | 330007566 | CISPLATIN |
| 330001956 | 330001113 | null | 77.2 | Palliative (P) | 2013-09-22 | 2013-09-24 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007566 | TRIAL |
| 330001957 | 330001113 | null | 65.9 | Curative (C) | 2017-10-06 | 2017-10-10 | AML Interim Guidelines | N | Y | 330007566 | NOT MATCHED |
| 330001958 | 330001114 | 1.69 | 68.1 | Curative (C) | 2016-04-08 | 2016-05-18 | Cisplatin 7 day | N | N | 330007575 | CISPLATIN |
| 330001959 | 330006599 | 1.8 | 84 | Curative (C) | 2017-11-13 | 2018-01-26 | NB HRNBL-1 BUMEL MAT | null | N | 330007576 | NOT MATCHED |
| 330001960 | 330006599 | 1.7 | 83.6 | Curative (C) | 2014-07-27 | 2014-08-12 | Cisplatin | N | Y | 330007576 | CISPLATIN |
| 330001961 | 330006599 | 1.86 | null | Curative (C) | null | 2017-01-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330007576 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001962 | 330001115 | 1.81 | 76.1 | Curative (C) | null | 2015-06-06 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330007581 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001963 | 330001116 | 1.1 | null | Curative (C) | 2017-05-28 | 2017-05-28 | EMA High Dose | Y | N | 330007582 | NOT MATCHED |
| 330001964 | 330001117 | 1.32 | 59.1 | Neo-adjuvant (N) | 2013-11-20 | 2013-12-02 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007583 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001965 | 330006600 | 1.68 | 50.8 | Palliative (P) | 2013-02-25 | 2013-03-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007584 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001966 | 330006600 | 1.66 | 45.1 | Neo-adjuvant (N) | 2016-10-15 | 2016-11-18 | Cisplatin | null | Y | 330007584 | CISPLATIN |
| 330001967 | 330001118 | 0 | 99 | Curative (C) | 2012-09-01 | 2012-09-13 | EW EuroEwing 2012 Arm A VAI | N | N | 330007587 | TRIAL |
| 330001968 | 330001118 | 1.68 | 8.89 | Neo-adjuvant (N) | null | 2014-11-04 | Trial Unspecified | Y | N | 330007587 | TRIAL |
| 330001969 | 330001118 | 1.62 | 68.6 | Curative (C) | 2016-04-23 | 2016-04-29 | EW EuroEwing 2012 Arm A VAC | N | N | 330007587 | NOT MATCHED |
| 330001971 | 330006602 | 0 | null | Palliative (P) | 2013-08-11 | 2013-08-12 | OST Euramos 1 Closed Trial - Ai | null | N | 330007591 | NOT MATCHED |
| 330001972 | 330001120 | 1.61 | null | Neo-adjuvant (N) | 2017-07-19 | 2017-07-26 | Trial Unspecified | Y | Y | 330007594 | TRIAL |
| 330001973 | 330001120 | 1.55 | 48.4 | Curative (C) | 2013-09-08 | 2013-09-11 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007594 | NOT MATCHED |
| 330001974 | 330001121 | 1.75 | 61 | Curative (C) | 2016-02-06 | 2016-02-07 | Cisplatin | N | Y | 330007600 | CISPLATIN |
| 330001975 | 330001122 | 1.78 | 84 | Curative (C) | 2013-04-16 | 2013-04-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007601 | CISPLATIN + DOCETAXEL + FLUOROURACIL |